Clinical Validation of an Artificial Intelligence Tool to Predict Inversion Time
THAITI-V
1 other identifier
interventional
60
1 country
1
Brief Summary
Introduction: Inversion-recovery (IR) magnetic resonance (MR) sequences are commonly used to perform late-gadolinium enhancement (LGE) imaging during cardiac magnetic resonance (CMR) scans. Inversion Time (TI), i.e. the time between the 180° inverting pulse and the 90°-pulse, must be manually input to obtain optimal myocardium nulling. Determinants of this value are patient's, sequence, and contrast characteristics, and the time after contrast injection. The identification of the correct TI is pivotal to quality images. The determination of TI is mostly based on experience, and it can be challenging in some diseases and for less experienced operators. Aim of this study is to test in a clinical setting an Artificial Intelligence (AI) tool, which we developed to automatically predict TI in CMR post-contrast IR LGE sequences, named "THAITI". THAITI performance will be evaluated in terms of 1) quality of images obtained using the AI-predicted TI with a 4-point Likert scale; 2) quality of images obtained using the AI-predicted TI in terms of Contrast-Enhancement ratio, i.e. the signal intensity of enhanced/remote myocardium in CMR-LGE images; 3) numbers of images that need to be reacquired; 4) average time duration of CMR-LGE imaging.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable cardiovascular-diseases
Started Nov 2024
Shorter than P25 for not_applicable cardiovascular-diseases
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 11, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 12, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 20, 2024
CompletedFirst Submitted
Initial submission to the registry
February 25, 2025
CompletedFirst Posted
Study publicly available on registry
March 3, 2025
CompletedMarch 3, 2025
February 1, 2025
1 month
February 25, 2025
February 25, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Images quality proportion
Proportion of images with optimal/good quality
At examination
Secondary Outcomes (1)
contrast-enhancement ratio
At examination
Study Arms (2)
Operator-set TI (control group)
NO INTERVENTIONDuring the cardiovascular magnetic resonance scan, the TI is set by an experienced human operator as per standard clinical practice
THAITI-set TI
EXPERIMENTALDuring the cardiovascular magnetic resonance scan, the TI is set by the experimental software
Interventions
THAITI is an AI-based software which predicts on the fly personalised TI for late gadolinium enhancement imaging during cardiovascular magnetic resonance scans. The clinical investigators will be provided by the computer scientists investigators with a software, based on the developed AI model. During the CMR in the experimental group, investigators will input patients' data on the software (e.g. age, sex, dose of contrast…). The software will provide a TI value to be input in the MRI scanner. TI will be set accordingly to the AI prediction. A LGE series of 3 long axis (4-, 2- and 3-chambers view) and a short-axis stack will be acquired. For all the patients, a doctor expert in CMR will be at the scanner and quality check the images in real time. Every image where the myocardium is not optimally nulled will be repeated with a TI set by the CMR doctor.
Eligibility Criteria
You may qualify if:
- Patients in whom CMR-LGE is performed for a clinical reason
- Mixed cardiac conditions (including cardiomyopathies, ischemic heart disease, normal scans, focal and diffuse myocardial pathological processes)
- Both sexes
- Any age
- Availability of serum creatinine, measured within one month prior to CMR
- Provision of the written informed consent
You may not qualify if:
- Non-contrast CMR
- First-pass perfusion stress-CMR
- Absolute contraindication to CMR
- Inadequate overall image quality
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Istituto Auxologico Italiano IRCCS
Milan, Italy
MeSH Terms
Conditions
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 25, 2025
First Posted
March 3, 2025
Study Start
November 11, 2024
Primary Completion
December 12, 2024
Study Completion
December 20, 2024
Last Updated
March 3, 2025
Record last verified: 2025-02